Compare Cipta Sarana Medika Tbk. (DKHH) vs Reksa Dana Indeks Premier ETF IDX High Dividend 20 (XIHD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cipta Sarana Medika Tbk. vs Reksa Dana Indeks Premier ETF IDX High Dividend 20 — how do they compare? Cipta Sarana Medika Tbk. trades at Rp64 (market cap 163.22B), while Reksa Dana Indeks Premier ETF IDX High Dividend 20 trades at Rp609 (market cap 33.31B). The key difference: Cipta Sarana Medika Tbk. is far larger — about 4.9× Reksa Dana Indeks Premier ETF IDX High Dividend 20's market cap. Which is the better fit depends on your goals.
| DKHH | XIHD | |
|---|---|---|
Market Cap | 163.22B | 33.31B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cipta Sarana Medika Tbk.
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →
